The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 01, 2023

Filed:

Jan. 30, 2018
Applicants:

Vect-horus, Marseilles, FR;

Centre National DE LA Recherche Scientifique, Paris, FR;

Universite D'aix-marseille, Marseilles, FR;

Inventors:

Cédric Malicet, Marseilles, FR;

Pascaline Lecorche, Marseilles, FR;

Jonathan Nowak, Marseilles, FR;

Marion David, Marseilles, FR;

Jamal Temsamani, Nimes, FR;

Michel Khrestchatisky, Marseilles, FR;

Assignees:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 51/08 (2006.01); A61K 51/04 (2006.01); C07K 7/06 (2006.01); G01N 33/574 (2006.01); G01N 33/60 (2006.01); G01N 33/92 (2006.01);
U.S. Cl.
CPC ...
A61K 51/088 (2013.01); A61K 51/048 (2013.01); C07K 7/06 (2013.01); G01N 33/57438 (2013.01); G01N 33/60 (2013.01); G01N 33/92 (2013.01); A61K 2121/00 (2013.01); A61K 2123/00 (2013.01);
Abstract

The present invention relates to a conjugated compound comprising a marker M pharmaceutically acceptable, and a peptide or pseudo-peptide P having at most 30 amino acid residues and able to bind the Low-Density Lipoprotein Receptor (LDLR) and to its use in a method of labelling and/or detecting and/or treating cancerous cells in a subject by administration of the conjugated compound to the subject an analysis of the presence and/or the amount of marker.


Find Patent Forward Citations

Loading…